Touch Surgery officially the largest worldwide community of surgeons practicing surgery virtually

Touch Surgery today at “Gadget Show Live” officially announced worldwide reach with users in all 206 UN recognised countries and territories. The platform is the largest and fastest growing community of surgeons learning and rehearsing operations digitally. Additionally, Touch Surgery has launched the first in a series of platform updates that will enable surgeons to collaboratively develop a knowledge base of surgical techniques and best practices.

The Touch Surgery app is the world’s first universally accessible virtual surgical training and rehearsal platform, available for free on iOS and Android. Founded by surgeons, Touch Surgery aims to facilitate the dissemination of surgical best practices and novel procedures, raise the standards of surgical care and improve patient outcomes, all through the use of mobile technology. To date, Touch Surgery hosts more than 40 virtual surgical simulations currently available on the Touch Surgery app, authored in conjunction with expert surgeons at leading international medical institutions.

Touch Surgery CEO and Co-Founder Dr Jean Nehme, MBBS said:

As of a few weeks ago, we can confirm that Touch Surgery, by working with expert surgeons at top medical institutions worldwide, is on the phones and tablets of surgeons and students in every single country worldwide. We’re excited to be able to empower the Touch Surgery community of surgeons to develop the most thorough and interactive resource for surgical practice. The integration of various collaboration functionalities will allow surgeons from all corners of the globe to collect, discuss, compare, and develop surgical standards, and we hope will ultimately translate into increasing in the quality of care and accessibility of training worldwide.

Source: Touch Surgery

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
You might also like... ×
Trial assesses tissue plasminogen activator as a treatment for COVID-19-related respiratory failure